Wilson Sonsini Goodrich & Rosati has advised Dayra Therapeutics. Dayra Therapeutics, a biotechnology start-up focused on advancing oral macrocyclic peptide therapeutics, has entered into a research…
Dayra Therapeutics Announces Research Collaboration with Biogen

























